PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 5:17 AM ET

Sponsor Check › Person

JJ
No photo found yet (own website and image search run after this page is viewed)

James Jenson

Named as an officer, director or promoter on SEC Form D filings · MA · Nov 12, 2013 → Oct 7, 2024

3deals (issuers)
$15.4Mreported sold
55investors
9Form D filings
2013–2024years on file
Follow this personLook further ↓PDF

Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 2:21 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET

The short version

James Jenson is listed as an executive officer and director on 9 SEC Form D filings by 3 issuers between Nov 2013 and Oct 2024: Morphoceuticals, Inc. (Medford, MA — biotechnology — 2024; $9.82M reported sold to 3 investors), CytoSite BioPharma Inc. (Sudbury, MA — biotechnology — 2017–2020; $4.42M reported sold to 13 investors) and Sabik Medical Inc. (Sudbury, MA — biotechnology — 2013–2015; $1.11M reported sold to 39 investors).

What this means A repeat sponsor — 3 separate companies raised money with this person listed as executive officer and director, over about 11 years. Across those companies the filings report $15.4M sold in total.

Listed alongside Ellen Cordo (5 shared filings), Richard Smith (5 shared filings), Stephen Sands (4 shared filings), Howard Fillit (3 shared filings), Mark Mintun (3 shared filings) and 11 others.

What this means These are the other officers, directors or promoters the companies named on the same forms — the team around James. Each name links to their own page.

2 of the issuers belong to the sponsor group Sabik (2 issuers, $4.05M reported sold, 2013–2020).

What this means A sponsor group is one team that sets up a new company for each deal. Sabik has 2 companies on file and $4.05M reported sold in total — the group page shows the whole track record in one place.

Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 1 court case matching the name, 9 bankruptcy cases matching the name listed in Key records below.

What this means 10 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.

We compared 9 public filings for James Jenson and found 5 differences: Form D filed 20 days after the first sale; Offering amount changed between filings; and more below.

What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.

What the community is saying

Community search for James Jenson has not run yet — it is joining a line of 11,920 names; searches run around the clock at the hosts' allowed rate. Searched so far: 27 names.

Community comments are quoted as written by their authors. Sources searched: BiggerPockets forums (via DuckDuckGo, Brave, Bing and BiggerPockets search) and Reddit (search feed + public archive).

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

1 case: 1 judgment

JAMES L.JENSON v. UNITED STATES OF AMERICA,ET AL judgment
District Court, D. Nevada · No. · Filed Dec 3, 1992 · Closed Apr 21, 1993 · Nature of suit: 190 Other contract actions
Role of JAMES L.JENSON: Plaintiff · Outcome: Terminated 1993-04-21 — FJC Integrated Database disposition: Judgment on motion before trial; judgment for defendant Docket on CourtListener ↗
same full name (a name found in 13 federal dockets); 2 people with this name in Form D filings; court in NV (not a filing state)
What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:21 AM ET.

Court records show docket facts only; we never restate allegations as facts. Outcome wording comes from the docket feed; where it does not state a disposition we say so.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: AZ, CA, DE, TX, WA (crawled Oct 23, 2026)

What was searched

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched James Jenson..

State securities regulators searched: AZ (Corporation Commission Securities Division), CA (DFPI — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE (DOJ Investor Protection Unit), TX (State Securities Board), WA (DFI) — last crawled Oct 23, 2026, 9:57 PM ET. Other states are not covered.

3. Bankruptcies

9 cases: 9 closed (disposition not in docket feed)

JAMES E JENSON, JR. closed
United States Bankruptcy Court, D. Minnesota · No. 12-60499 · Filed May 30, 2012 · Closed Mar 18, 2016
Role of JAMES E JENSON, JR.: Debtor · Outcome: Case closed 2016-03-18 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 13 federal dockets); 2 people with this name in Form D filings; court in MN (not a filing state)
James J. Jenson closed
United States Bankruptcy Court, D. Maine · No. 11-10090 · Filed Jan 27, 2011 · Closed Jul 5, 2011
Role of James J. Jenson: Debtor · Outcome: Case closed 2011-07-05 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 13 federal dockets); 2 people with this name in Form D filings; court in ME (not a filing state)
James H. Jenson closed
United States Bankruptcy Court, N.D. Illinois · No. 09-44753 · Filed Nov 25, 2009 · Closed Apr 23, 2010
Role of James H. Jenson: Debtor · Outcome: Case closed 2010-04-23 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 13 federal dockets); 2 people with this name in Form D filings; court in IL (not a filing state)
JAMES E JENSON and ROCHELLE M JENSON closed
United States Bankruptcy Court, D. Minnesota · No. 08-60425 · Filed Apr 28, 2008 · Closed Oct 21, 2011
Role of JAMES E JENSON and ROCHELLE M JENSON: Debtor · Outcome: Case closed 2011-10-21 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 13 federal dockets); 2 people with this name in Form D filings; court in MN (not a filing state)
James L Jenson closed
United States Bankruptcy Court, W.D. Washington · No. 04-42555 · Filed Mar 16, 2004 · Closed Jun 29, 2004
Role of James L Jenson: Debtor · Outcome: Case closed 2004-06-29 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 13 federal dockets); 2 people with this name in Form D filings; court in WA (not a filing state)
JAMES K JENSON and MARY LOU J JENSON closed
United States Bankruptcy Court, D. Minnesota · No. 03-60495 · Filed Apr 17, 2003 · Closed Nov 29, 2004
Role of JAMES K JENSON and MARY LOU J JENSON: Debtor · Outcome: Case closed 2004-11-29 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 13 federal dockets); 2 people with this name in Form D filings; court in MN (not a filing state)
James L. Jenson and Amy M. Jenson closed
United States Bankruptcy Court, S.D. California · No. 01-01633 · Filed Feb 20, 2001 · Closed May 29, 2001
Role of James L. Jenson and Amy M. Jenson: Debtor · Outcome: Case closed 2001-05-29 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 13 federal dockets); 2 people with this name in Form D filings; court in CA (not a filing state)
James D Jenson closed
United States Bankruptcy Court, D. Idaho · No. 98-30473 · Filed Nov 3, 1998 · Closed Mar 16, 1999
Role of James D Jenson: Debtor · Outcome: Case closed 1999-03-16 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 13 federal dockets); 2 people with this name in Form D filings; court in ID (not a filing state)
James L. Jenson closed
United States Bankruptcy Court, W.D. Louisiana · No. 91-11267 · Filed May 14, 1991 · Closed Oct 5, 1994
Role of James L. Jenson: Debtor · Outcome: Case closed 1994-10-05 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 13 federal dockets); 2 people with this name in Form D filings; court in LA (not a filing state)
What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:21 AM ET.

Court records show docket facts only; we never restate allegations as facts. Outcome wording comes from the docket feed; where it does not state a disposition we say so.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

Comparisons cover issuers and sponsor groups — see the issuer pages under Deals

5 differences found between the filings for James Jenson (compared 9 filings on Oct 24, 2026)

Note · Oct 23, 2013 – Nov 12, 2013

Form D filed 20 days after the first sale — Sabik Medical Inc.

The filing says the first sale was Oct 23, 2013. The Form D was filed Nov 12, 2013 — 20 days later. The rule: a Form D is generally due within 15 days after the first sale, so this one is 5 days past that.

What this means A late notice is common and carries no penalty by itself. It is worth asking the sponsor why the paperwork lagged.

Form D · Nov 12, 2013 ↗Sabik Medical Inc. — PartnerFacts page ↗
Sources
Note · Nov 12, 2013 – May 20, 2014

Offering amount changed between filings — Sabik Medical Inc.

The Nov 12, 2013 filing says $857,576 offered; the May 20, 2014 Form D/A says $1,114,081.

What this means The target raise changed. Raising the cap is common when a deal grows; ask whether the extra money has the same terms and use.

Form D (earlier) · Nov 12, 2013 ↗Form D/A (later) · May 20, 2014 ↗Sabik Medical Inc. — PartnerFacts page ↗
Sources
Note · Sep 23, 2024 – Oct 7, 2024

No amendment in the last 12 months on an offering that may still be open — Morphoceuticals, Inc. (latest filing Oct 7, 2024)

The latest filing for this offering is dated Oct 7, 2024 (first sale Sep 23, 2024). It reports $3,500,000 sold of $5,500,000 offered. No later amendment is in our index as of Oct 24, 2026.

What this means SEC rules expect a yearly amendment while an offering is still going. The raise may simply have ended — a Form D does not say when it closed. Ask the sponsor whether the offering closed, when, and at what amount.

Form D · Oct 7, 2024 ↗Morphoceuticals, Inc. — PartnerFacts page ↗
Sources
Note · Sep 10, 2019 – Oct 5, 2020

No amendment in the last 12 months on an offering that may still be open — CytoSite BioPharma Inc. (latest filing Oct 5, 2020)

The latest filing for this offering is dated Oct 5, 2020 (first sale Sep 10, 2019). It reports $3,049,985 sold of $5,099,995 offered. No later amendment is in our index as of Oct 24, 2026.

What this means SEC rules expect a yearly amendment while an offering is still going. The raise may simply have ended — a Form D does not say when it closed. Ask the sponsor whether the offering closed, when, and at what amount.

Form D/A · Oct 5, 2020 ↗CytoSite BioPharma Inc. — PartnerFacts page ↗
Sources
Note · Apr 30, 2015 – May 14, 2015

No amendment in the last 12 months on an offering that may still be open — Sabik Medical Inc. (latest filing May 14, 2015)

The latest filing for this offering is dated May 14, 2015 (first sale Apr 30, 2015). It reports $998,672 sold of $2,000,000 offered. No later amendment is in our index as of Oct 24, 2026.

What this means SEC rules expect a yearly amendment while an offering is still going. The raise may simply have ended — a Form D does not say when it closed. Ask the sponsor whether the offering closed, when, and at what amount.

Form D · May 14, 2015 ↗Sabik Medical Inc. — PartnerFacts page ↗
Sources
What is compared

What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.

5. Money to insiders

0 of 7 offerings report sales commissions; 0 report finder's fees; 2 report proceeds to related persons totalling $150,000. (includes amounts the issuer reported as estimates)

Offering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell itSource
Oct 7, 2024 D
Morphoceuticals, Inc.
File 021-526068
$0$0$0None listed on this filingEDGAR ↗
Oct 5, 2020 D/A
CytoSite BioPharma Inc.
File 021-349481
$0$0$0
None except for normal operation expenses
None listed on this filingEDGAR ↗
Aug 16, 2018 D
CytoSite BioPharma Inc.
File 021-319424
$0$0$0
None except for normal operation expenses
None listed on this filingEDGAR ↗
May 9, 2018 D
CytoSite BioPharma Inc.
File 021-311995
$0$0$0
None except for normal operation expenses
None listed on this filingEDGAR ↗
Dec 18, 2017 D
CytoSite BioPharma Inc.
File 021-301053
$0$0$0
None except for normal operation expenses
None listed on this filingEDGAR ↗
May 14, 2015 D
Sabik Medical Inc.
File 021-239815
$0$0$50,000 (est.)None listed on this filingEDGAR ↗
May 20, 2014 D/A
Sabik Medical Inc.
File 021-206136
$0$0$100,000 (est.)None listed on this filingEDGAR ↗
How this is counted

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Deals 3

Every issuer that named James Jenson on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.

M
Biotechnology

Morphoceuticals, Inc.

Medford, MA · Oct 7, 2024
  • Oct 7, 2024 · D · $3,500,000 sold of $5,500,000 · 1 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗

Raised $9.82M from 3 investors (100% of the $5.5M target) as of the latest filing. James is listed as executive officer, director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

CB
Biotechnology · group: Sabik

CytoSite BioPharma Inc.

Sudbury, MA · Dec 18, 2017 → Oct 5, 2020 · 5 filings
  • Oct 5, 2020 · D/A · $3,049,985 sold of $5,099,995 · 12 investors · min. No minimum reported · role: Executive Officer, Director (Director, President and Chief Executive Officer) EDGAR ↗
  • Sep 24, 2019 · D · $2,549,995 sold of $5,099,995 · 12 investors · min. No minimum reported · role: Executive Officer, Director (Director, President and Chief Executive Officer) EDGAR ↗
  • Aug 16, 2018 · D · $4,424,985 sold of $4,424,985 · 13 investors · min. No minimum reported · role: Executive Officer, Director (Director, President and Chief Executive Officer) EDGAR ↗
  • May 9, 2018 · D · $125,000 sold of $125,000 · 1 investors · min. No minimum reported · role: Executive Officer, Director (Director, President and Chief Executive Officer) EDGAR ↗
  • Dec 18, 2017 · D · $10,760 sold of $10,760 · 2 investors · min. No minimum reported · role: Executive Officer, Director (Director, President and Chief Executive Officer) EDGAR ↗

Raised $4.42M from 13 investors (87% of the $5.1M target) as of the latest filing. James is listed as executive officer, director on 5 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

SM
Biotechnology · group: Sabik

Sabik Medical Inc.

Sudbury, MA · Nov 12, 2013 → May 14, 2015 · 3 filings
  • May 14, 2015 · D · $998,672 sold of $2,000,000 · 39 investors · min. $5,000 · role: Executive Officer, Director EDGAR ↗
  • May 20, 2014 · D/A · $1,114,081 sold of $1,114,081 · 29 investors · min. $5,000 · role: Executive Officer, Director EDGAR ↗
  • Nov 12, 2013 · D · $857,576 sold of $857,576 · 23 investors · min. $5,000 · role: Executive Officer, Director EDGAR ↗

Raised $1.11M from 39 investors (56% of the $2M target) as of the latest filing. James is listed as executive officer, director on 3 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Other pages with the same name (1)

Separate person records under the same name, not combined with this page. Each line says whether it shares an issuer with this record.

  • James C. Jenson — MA, 1 issuer, Jun 28, 2010 → Oct 28, 2010 · no shared issuer

People around James 16

Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET.

RS
No photo found yet (own website and image search run after this page is viewed)
Person

Richard Smith

Executive Officer · 5 shared filings (1 issuer)

Listed on the same filings as James Jenson. Their page shows their other deals.

EC
No photo found yet (own website and image search run after this page is viewed)
Person

Ellen Cordo

Executive Officer · 5 shared filings (1 issuer)

Listed on the same filings as James Jenson. Their page shows their other deals.

SS
No photo found yet (own website and image search run after this page is viewed)
Person

Stephen Sands

Director · 4 shared filings (2 issuers) · also on 1 other issuer

Listed on the same filings as James Jenson. Their page shows their other deals.

RG
No photo found yet (own website and image search run after this page is viewed)
Person

Robert Gailus

Director · 3 shared filings (1 issuer) · also on 5 other issuers

Robert Gailus is on 6 issuers in total — a repeat sponsor. Their page lists every one.

HF
No photo found yet (own website and image search run after this page is viewed)
Person

Howard Fillit

Director · 3 shared filings (1 issuer)

Listed on the same filings as James Jenson. Their page shows their other deals.

MC
No photo found yet (own website and image search run after this page is viewed)
Person

Michel Chu

Director · 3 shared filings (1 issuer)

Listed on the same filings as James Jenson. Their page shows their other deals.

MM
No photo found yet (own website and image search run after this page is viewed)
Person

Mark Mintun

Director · 3 shared filings (1 issuer)

Listed on the same filings as James Jenson. Their page shows their other deals.

AG
No photo found yet (own website and image search run after this page is viewed)
Person

Allan Green

Executive Officer, Director · 2 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as James Jenson. Their page shows their other deals.

DP
No photo found yet (own website and image search run after this page is viewed)
Person

Daniel Peters

Director · 2 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as James Jenson. Their page shows their other deals.

EE
No photo found yet (own website and image search run after this page is viewed)
Person

Eric Evans

Director · 1 shared filing (1 issuer)

Listed on the same filings as James Jenson. Their page shows their other deals.

RD
No photo found yet (own website and image search run after this page is viewed)
Person

Ray Dunn

Director · 1 shared filing (1 issuer)

Listed on the same filings as James Jenson. Their page shows their other deals.

MH
No photo found yet (own website and image search run after this page is viewed)
Person

Michael Hufford

Director · 1 shared filing (1 issuer) · also on 1 other issuer

Listed on the same filings as James Jenson. Their page shows their other deals.

AP
No photo found yet (own website and image search run after this page is viewed)
Person

Alexander Pickett

Director · 1 shared filing (1 issuer)

Listed on the same filings as James Jenson. Their page shows their other deals.

RH
No photo found yet (own website and image search run after this page is viewed)
Person

Rosemarie Hunziker

Director · 1 shared filing (1 issuer)

Listed on the same filings as James Jenson. Their page shows their other deals.

JB
No photo found yet (own website and image search run after this page is viewed)
Person

Justin Briggs

Director · 1 shared filing (1 issuer) · also on 1 other issuer

Listed on the same filings as James Jenson. Their page shows their other deals.

TT
No photo found yet (own website and image search run after this page is viewed)
Person

Tamim Hamad J.J Al-Thani

Director · 1 shared filing (1 issuer)

Listed on the same filings as James Jenson. Their page shows their other deals.

The team behind the deals

S
Sponsor group

Sabik

2 issuers · 8 filings · $4.05M reported sold · 2013–2020

One team, 2 deal companies. James Jenson is listed on 2 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name James Jenson.

Registrations and other filings

Adviser registration (Form ADV)

None of the 3 issuers this person is listed on appears in Form ADV (searched 24,962 advisers as of Oct 2, 2026). A person is never an adviser firm; Form ADV is checked for the issuers and the management companies they are listed with.

Other offering types (Regulation A and Regulation Crowdfunding)

Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.

Property records none — individuals are not matched

Property records are matched to companies only, never to individuals, so none are matched to James Jenson by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 3 issuers this person is listed on — nothing matched.

Public profiles and social

Websites and social links of the issuers James Jenson is listed on: none on file. No website or social profile named in Morphoceuticals, Inc.'s SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #89,317 of 374,652 in line (14 issuers searched so far). One-tap searches: Look further ↓

Look further

One-tap searches on sites we do not index ourselves, with the name pre-filled (Medford, MA). Each opens in a new tab; what you find there is not verified by PartnerFacts.

Social and web

LinkedIn people search ↗Instagram ↗X (Twitter) ↗Facebook ↗YouTube ↗Google ↗Google Images ↗Google News ↗Meta Ad Library ↗

Courts

CourtListener / RECAP (federal) ↗PACER case locator (federal, login) ↗Massachusetts MassCourts ↗

Securities regulators

SEC EDGAR full-text search ↗SEC action look-up ↗FINRA BrokerCheck ↗SEC IAPD adviser search ↗

Business registries

Massachusetts Secretary of State business search ↗OpenCorporates ↗

Change history

No corrections have been requested for this page.

Every fact links to its public-record source. Plain-English notes next to a fact are our reading of that fact, not a rating. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this person

Members get an email when James Jenson appears on a new Form D, or when a court case or SEC action is matched to them. See plans →